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Abstract 
A robust on-line automatic filtration and filter-flush solid phase extraction liquid 
chromatography tandem mass spectrometry (AFFL-SPE-LC- MS/MS) method for 
determination of 25hydroxycholesterol (25HC), 24S hydroxycholesterol (24SHC) and 22S 
hydroxycholesterol (22SHC) in cell samples has been developed.  Only one sample 
transfer (from sample tube to LC vial) was needed for the entire process of cell lysis, 
derivatization and determination of the analytes. 
In general, cell lysate samples (200-400 µL) were mixed with internal standard and 
evaporated into dryness. The samples were resolved in 2-propanol and phosphate 
buffer (pH 7) followed by an oxidation with cholesterol oxidase. Subsequently, methanol 
and acetic acid were added to the samples and the samples were derivatized with 
Girard T reagent. Aliquots of 100 µL were injected directly on to the AFFL-SPE-LC-MS/MS 
system.  
The method was validated and showed good linearity (R2>0.99 in the concentration 
range 0.3- 33 nM). The limit of detection was 0.06 nM (2.5 pg injected on column) and 
the limit of quantification was found to be 0.3 nM. Repeatability was satisfying at three 
concentration levels, low (0.3 nM), medium (2.1 nM) and high (33 nM), where the 
relative standard deviation (RSD) between replicates (n=6) were 15-19 %, 5-13 % and 5-
6 %, respectively. RSD between days (n=5) were 6-16 %, 9-12 % and 5-9 %, respectively.  
The method was applied for analysis of different cell lines (NIH3T3, SHh-L2, SUFU-/-, 
HEK293, HCT15 and HCT116). The between cell flask concentration variation was low 
(RSD=5-35 %, except for 24SHC in Shh-LII (RSD= 65%)) implying method robustness. The 
method was also applied successfully for a cell subpopulation of 330 000 cells.   
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Abbreviations 
13C-HC-GT 13C labeled Girard T derivatized oxysterol 
20αHC 20α hydroxycholesterol 
20αHC-GT Girard T derivative of 20α hydroxycholesterol 
22SHC 22S hydroxycholesterol 
22SHC-GT Girard T derivative of 22S hydroxycholesterol 
24SHC 24S hydroxycholesterol 
24SHC-GT Girard T derivative of 24S hydroxycholesterol 
25HC 25 hydroxycholesterol 
25HC-GT Girard T derivative of 25 hydroxycholesterol 
25d6HC 25 hydroxycholesterol 26,26,26,27,27,27 d6 
25d6HC-GT Girard T derivative of 25 hydroxycholesterol 26,26,26,27,27,27 d6 
ACN Acetonitrile 
AFFL Automated filtration and filter flush 
CH13C Cholesterol 25,26,27 13C 
Clog P Calculated log P (partition coefficient) 
CSCs Cancer stem cells 
EI Electron ionization 
EIC Extracted ion chromatogram 
ESI Electrospray ionization 
FA Formic acid 
FBS Fetal bovine serum 
GC Gas chromatography 
Hh Hedgehog 
i.d. Inner diameter 
IT Ion trap 
LC Liquid chromatography 
LOD Limit of detection 
LOQ Limit of quantification 
MeOH Methanol 
MRM Multi reaction monitoring 
MS Mass spectrometry 
MS/MS Tandem mass spectrometry 
MSn Multidimensional MS 
m/z Mass to charge ratio 
NMR Nuclear magnetic resonance 
Ptch Patched1 
RP Reversed phase chromatography 
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RSD Relative standard deviation 
S/N Signal to noise ratio 
Smo Smoothened 
SPE Solid phase extraction 
SRM Single reaction monitoring 
STD Standard deviation 
TIC Total ion chromatogram 
Vim + Vimentin positive 
Vim -  Vimentin negative 
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1  Introduction 
1.1  Oxysterols 
Oxysterols are formed in the body by enzymatic oxidation or autoxidation of 
cholesterol; hence they are oxidation products [1-7]. Oxysterols can also be obtained 
from dietary sources [2, 7], such as cholesterol rich food. Widely distributed in the body, 
both in blood and tissue, oxysterols can exist in different conjugated forms. The 
oxysterols themselves are biologically active molecules and some of them are under 
investigation as potential biomarkers for neurogenerative diseases such as Alzheimer 
and multiple sclerosis [2, 4, 5, 8-10]. 
The structure of the precursor cholesterol and the oxysterols under investigation in this 
study are shown in Figure 1. These has been chosen as analytes, as they have been seen 
to be potential inhibitors of the Hedgehog pathway [11], which will be presented 
chapter 1.2. The names of the oxysterols are given by the localization of hydroxyl 
groups. For instant, if hydroxyl groups are attached to carbon number 3 and 25, its 
name is 25 hydroxycholesterol.  
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Figure 1 Structure of cholesterol, 22S hydroxycholesterol, 25 hydroxycholesterol, 24S hydroxycholesterol and 20α 
hydroxycholesterol. 
 
Oxysterols regulate cholesterol homeostasis [10, 12] and can act as intermediates of 
cholesterol in bile acid synthesis. Oxysterols are therefore involved in removing excess 
cholesterol from the body [10]. In addition oxysterols can act as transport molecules for 
cholesterol in the body and over the blood-brain barrier [3, 4]. Studies have shown the 
carcinogenic potential for specific oxysterols in different types of cancer, and it is in the 
context of cancer that the present study of oxysterols has been performed. Oxysterols 
can affect carcinogenesis in different ways, as shown in Figure 2 [10]. 
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Figure 2 Overview of different ways that oxysterols can affect carcinogenesis, adapted from [10]. 
 
 
1.2  The Hedgehog pathway 
A central pathway in cancer is the Hedgehog pathway. This pathway is strongly affected 
by oxysterols. The Hedgehog (Hh) gene was first discovered in the fruit fly Drosophila 
melanogaster in 1980 [13]. Hedgehog related genes have different expression in various 
tissues at different stages of development [14, 15]. The pathway is shown in Figure 3. 
Mutations in the Hh pathway are associated with cancer and tumor growth and stem 
cells. Cholesterol or derivatives of cholesterol, such as oxysterols have been found to be 
required for Hh signal transduction [11]. 
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The Hh pathway is activated when an Hh protein binds to the membrane protein 
Patched 1 (Ptch) on the target cell. Without the presence of an Hh protein, Ptch inhibits 
Smoothened (Smo) by an unknown mechanism. The mechanism is probably catalytical, 
not enzymatic, as one Ptch protein can inhibit several Smo proteins. Smo subsequently 
activates the Gli transcription factors, which ultimately onsets Hedgehog signaling [7, 
11, 15, 16]. 
 
 
Figure 3 the Hh signaling pathway. Adapted from: [16].  
 
The Hh pathway has different roles in embryos and human adults [14, 15]. During 
development of embryos, it contributes to development of structures and organs. In 
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human adults the Hh pathway regulates stem cell activity and thereby controls self-
renewal and maintenance of the organs [14-17]. Irregular activity or mutation in the Hh 
pathway may therefore cause tumor growth [11, 15, 16, 18]. Different models can 
explain irregularity and activation of the pathway which leads to tumor growth. 
However, it has been shown that specific oxysterols, especially 20α hydroxycholesterol, 
22S hydroxycholesterol and 25 hydroxycholesterol are important for Hh pathway signal 
transduction by stimulating Smo activity [7, 11, 18]. Hence, oxysterols can be “on” 
switches of Hh pathway. 
 
1.2.1 Cancer stem cells 
Stem cells are cells that are able to generate mature cells of a particular tissue through 
differentiation.  Stem cells have extensive prolife potential and are capable of self-
renewal. These properties of normal stem cells are very similar to the properties of 
tumor-initiative cells, which often are referred to, or nick named as cancer stem cells 
(CSCs) [19, 20]. The correctness of this term is disputed [21], but used here to describe 
tumor cells with stem cell-like traits. 
CSCs may develop from mutation of normal cells or from mutated progenitor cells [20]. 
As normal stem cells, they share the extensive prolife potential and can give rise to 
development of new tissue, normal or abnormal (tumor). CSCs are essential for tumor 
growth and may be responsible for tumor relapse after treatment [19, 20]. 
With the same characteristics as regular stem cells, CSCs are regulated by the same 
signal molecules and pathways. Hh signal regulates stem cell activity and also control 
CSCs activity and tumor growth. Cancer tumors can often only contain a small number 
of CSCs and these are often resistant to conventional chemotherapy and radiation [19, 
20]. CSCs are slow cycling and may be the cause of cancer relapse after tumor is 
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removed by surgery or radiation (Figure 4). Active Hh signaling has been associated with 
CSCs. By targeting the CSCs with Hh inhibitors, the tumor may be stopped. However, 
since oxysterols are initiators of Hh, they may compete with Hh inhibitors, reducing 
their effect. Hence, oxysterols play a central role in cancer, stem cells and signal 
pathways. In order to examine the pathway and study how oxysterols possibly affect 
this pathway, sensitive and robust methods for determination of oxysterols in biological 
samples must be available. 
 
 
Figure 4 Cancer stem cells are often resistant to conventional cancer therapy and may cause the cancer to relapse 
after the tumor is removed. By targeting cancer stem cells, e.g. with an Hh inhibitor, tumor may be stopped. 
Adapted from: [19]. 
  
 
19 
 
1.3  Determination of oxysterols 
As seen in Figure 1, the oxysterols are small neutral molecules.  The oxysterols under 
investigation in this study are isobaric with a molecular mass of 402.65 g/mol (mono 
isotopic/exact mass 402.35 g/mol). Their structures differ only in location of one 
hydroxyl group. Hence a separation is necessary before detection by mass spectrometry 
(MS). Steroids have traditionally been quantified with gas chromatography (GC) after a 
derivatization to make them volatile enough for GC determination. This derivatization 
can require substantial manual efforts. In addition, some of the oxysterols may not be 
sufficient thermally stable for the temperatures required in GC [1, 2]. GC is often 
combined with a MS as detector, equipped with a hard ionization source such as 
electron ionization (EI). EI often makes extended fragmentation of biological molecules, 
such as the oxysterols. Identification of the molecular ion in the mass spectra and 
thereby determination of molecular mass can be difficult [8, 22, 23].  
Oxysterols can be separated with liquid chromatography (LC). However, oxysterols as 
oxidation products of cholesterol are present in a low concentration (ng/g-µg/g) against 
a high background of cholesterol (mg/g) [4, 8]. The wide range in concentration puts 
high demands on the dynamic range of the detector and the chromatographic system 
[3-5, 23, 24]. A method, either using GC or LC, must be able to provide sufficient 
separation with sufficient sensitivity for the low concentration of oxysterols, without 
overloading the column with cholesterol. 
The most common ionization source for LC MS is electrospray ionization (ESI), a soft 
ionization method suitable for biomolecules [25]. ESI gives little fragmentation and 
molecule mass information is often obtained [4, 25, 26]. However, the oxysterols are 
small neutral molecules with no acidic or basic groups; hence they are not easily ionized 
by ESI [1-3, 8, 22, 23]. A derivatization prior to analysis is hence necessary to make the 
ionization more efficient. 
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Different methods for derivatization of oxysterols are described in literature [1, 2, 8]. A 
quaternary nitrogen molecule can be introduced into oxidized oxysterols by 
derivatization with Girard P reagent and give the oxysterols a charge of +1 [27, 28]. This 
two-step reaction is shown in Figure 5 and Figure 6. First, an enzymatic oxidation with 
cholesterol oxidase, a bacterial enzyme, catalyzes the oxidation of C-OH located on the 
ring (C3 in Figure 1) into ketone. The reaction is performed at 37 °C for one hour in ~10 
% 2-propanol in phosphate buffer pH 7. An increase in the 2-propanol concentration will 
decrease the activity of the cholesterol oxidase enzyme [29]. 
 
 
Figure 5 Enzymatic oxidation of 20α hydroxycholesterol with cholesterol oxidase. 
 
Second, the carbonyl group (ketone) is derivatized into Girard P hydrazone with Girard P 
reagent. Due to the quaternary nitrogen group in the Girard P reagent, derivatized 
oxysterols are already ionized when entering the ESI. Mass spectrometry sensitivity 
improves by two or three orders of magnitude compared to underivatized oxysterols 
[8]. In addition, the solubility of the derivatized oxysterols in the aqueous mobile phases 
used in reversed phase chromatography is enhanced [3-5, 8, 23, 24]. 
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Figure 6 Derivatization of oxidized 20α hydroxycholesterol with Girard P reagent. 
 
 The Girard P reagent can be replaced with the Girard T reagent, both reagents are 
shown in Figure 7 [30]. As seen from the figure, the reagents only differ in the 
substituent on the quaternary nitrogen; the Girard P reagent has a benzene ring, while 
the Girard T reagent has three methyl groups attached to the nitrogen. By calculation of 
log P (CLog P) values using ChemBioDraw (PerkinElmer Informatics, Cambridge, MA, US) 
for both reagents, the value of Girard T is found more negative then Girard P; hence 
Girard T is more hydrophilic. Solubility of the derivatives in aqueous solution should be 
higher when Girard T is used for derivatization. Better solubility in the mobile phase 
used for reversed phase chromatography is expected. In this study, LC MS/MS with 
22 
 
charge tagging using Girard T reagent has been employed. Structure of the Girard T 
derivative of 25 hydroxycholesterol is shown in Figure 8. 
 
 
Figure 7 Structure of a) Girard T and b) Girard P reagent with log P values. 
 
Since oxysterols are oxidation products of cholesterol and are present at  a low 
concentration compared to cholesterol, even a low extent of autoxidation of cholesterol 
during sample preparation will affect quantification of oxysterols [28]. Monitoring 
autoxidation is therefore important to avoid identification and quantification errors. 
Cholesterol can be oxidized when exposed to air, light and increased temperatures. By 
addition of labeled cholesterol, autoxidation can be monitored [28, 31]. If oxidation of 
cholesterol occurs during sample preparation, the heavy cholesterol should also 
undergo oxidation, creating oxysterols with a higher mass, but otherwise share similar 
characteristics with the analytes. 
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Figure 8 Structure of Girard T derivative of 25 hydroxycholesterol. 
 
 
1.4  Sample clean-up procedure 
During the derivatization reactions, excess reagents are added to the sample. A sample 
clean-up is hence necessary before introducing the samples into a LC system to avoid 
overloading the column. Column overloading can cause peak broadening. In addition, 
introduction of excess reagent can contaminate the MS. Sample clean-up is most often 
performed off-line on Solid Phase Extraction (SPE) columns, or less often, on-line in a 
column switching system. 
 
1.4.1 Column switching 
SPE can be automated in an on-line approach by applying a column switching system. 
An on-line switching procedure also allows large volumes of sample being injected on a 
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narrow column in a short time, without destroying chromatographic performance. A 
schematic view of a column switching system is shown in Figure 9. In general, the 
sample is transferred by a loading pump to a trap column using a non-eluting solvent. 
The analytes are trapped in a narrow band on the trap column. All non-retained 
components (e.g. solvents, derivatization reagents) are eluted to waste. When the valve 
is switched, an analytical pump elutes the analytes from the trap column, still in a 
narrow band, transferring the analytes to the analytical column for separation. In this 
study, on-line SPE LC was employed.  
 
 
Figure 9 Column switching system in a) load position and b) inject position. 
 
However, column switching systems have some disadvantages, such as easily clogging 
and pressure build up [32]. This pressure build up can be caused by accumulation of 
particles on the trap column (e.g. protein precipitates in biological samples). To avoid 
this pressure build up, an off-line filtration or off-line SPE procedure is often included in 
methods to protect the column switching system. However, this requires additional 
manual preparation steps. 
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1.4.2 Automated filtration and filter flush (AFFL)-SPE  
A novel robust automated filtration and filter flush (AFFL)-SPE system has been 
developed to automate the sample preparation, without pressure rise and clogging [33]. 
A schematic drawing of this 10 port valve system is shown in Figure 10. Sample, 
containing analyte (X), particle mater (P) and excess Girard T reagent (G) is loaded on 
the trap column after an in-line filtration through a stainless steel filter. The analytes are 
trapped on the trap column, while more hydrophilic compounds without retention, such 
as the Girard T reagent are eluted to waste. When the valve is switched, the analytical 
pump will elute the analytes and transfer them to the analytical column for separation. 
At the same time as the analytes are separated, a third pump back-flushes the filter. All 
particles are washed into waste and the filter becomes clean and ready for the next 
sample. With this filter back-flushing system, pressure build-up and clogging are 
avoided, and this system was used in this study.  
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Figure 10 AFFL-SPE-LC system for determination of oxysterols (X) in samples containing particulate matter 
(P), with the presence of excess derivatization reagent, Girard T (G). A) The mixture is loaded. B) Particulates 
are trapped on a stainless steel filter, oxysterols are trapped on a trap (SPE) column and excess reagent is 
flushed to waste. C) Oxysterols are eluted on to the analytical column, while particulate matters are back 
flushed off the stainless steel filter. 
 
 
1.5  Reversed phase chromatography 
Reversed phase (RP) chromatography is the most common separation principle used in 
liquid chromatography, probably due to the versatility, the high peak capacity and 
efficiency of the columns. The stationary phase in RP is non-polar or weakly polar and 
often consist of modified silica with hydrophobic groups attached as long alkyl chains. C8 
or C18 is most commonly used. The mobile phase in RP is polar and most often consist of 
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water or aqueous buffers and a water soluble organic solvent. An increase in the organic 
solvent amount will reduce the retention times. In this study, a C18 column was used. 
 
1.5.1 Column dimensions 
 By decreasing the inner diameter (i.d.) of the column, less chromatographic dilution will 
occur, and more concentrated analytes will elute. When using a concentration sensitive 
detector, such as ESI MS, lower detection limits will be achieved. There is no need for 
flow splitting e.g. between the column and the MS inlet as there is for larger i.d. 
columns. In addition, less mobile phase will be consumed. Lower mobile phase 
consumption has both economic and environmental benefits for the user. However, 
when using narrow columns, robustness can be an issue. Smaller dimensions give a 
larger probability for clogging, and dead volumes are more critical. In this study, a 
narrow bore column (i.d. 1 mm) was used. 
 
1.6  Electrospray ionization mass spectrometry 
In MS the m/z ratio (mass to charge) is measured for gas phase ions that can be 
separated e.g. electrically or magnetically [26]. In the ionization source compounds are 
ionized and vaporized. ESI is the most common soft ionization source used in LC MS. ESI 
gives less fragmentation because the energy is transferred gradually to the analyte by 
thermal energy at low temperatures. A drawing of the ESI is shown in Figure 11. In ESI, 
high voltage is applied and ions will migrate towards an opposite charged electrode. A 
Taylor cone is formed at the capillary outlet and breaks into small highly charged 
droplets. Continuously evaporation of solvent and droplet fission transfers the ions into 
gas phase [25, 34].  
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Figure 11 Drawing of electrospray ionization. When high voltage is applied, ions will move towards the opposite 
charged electrode forming a Taylor cone. Repulsive forces between the ions will break the cone into small highly 
charged droplets. These droplets undergo fission and create even smaller highly charged droplets. Eventually, gas 
phase ions will be produced.  
 
In this study, an ion trap (IT) MS was used. A schematic drawing is shown in Figure 12. 
The IT MS consists of three electrodes; one ring electrode placed between two end cap 
electrodes. When a radio frequency potential is applied on the ring electrode, a three 
dimensional field is created between the electrodes. This field traps ions by forcing 
them towards the center of the trap. Ions captured by the trap will follow projections 
determined by their m/z value. The ions are subsequently ejected out of the trap and 
detected by a detector.  
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Figure 12 Drawing of IT MS. Ions will be trapped in a three dimensional field between the electrodes. Ions will 
follow projections determined by their m/z value. Sequential ejection of ions with different m/z value is done by 
adjusting the potential between the electrodes. 
 
IT has high sensitivity and is able to perform multidimensional MS (MSn). By trapping 
only one m/z value followed by an induced fragmentation, structure information can be 
achieved. This will improve identification of analytes. In addition, better detection limits 
will be achieved, as fewer ions enter the detector; hence background noise level is 
lowered. IT can be programmed into single reaction monitoring (SRM) where one 
fragmentation reaction is monitored or multi reaction monitor (MRM) mode. MRM 
allows several fragmentation reactions to be monitored at the same time.  
 
1.6.1 Fragmentation of Girard P and Girard T derivatives of 
oxysterols 
Girard T and Girard P derivatives of oxysterols will fragment with a neutral loss of 59 Da 
and 79 Da in MS/MS mode, respectively [8, 35]. Analytes are therefore easily recognized 
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and identified with IT MS operated in MS/MS or MRM mode. Suggested fragmentation 
pattern for MS/MS and MS3 mode for Girard T derivatives are shown in Figure 13 [35]. 
 
 
Figure 13 Fragmentation of Girard T derivatives of oxysterols in MS/MS and MS
3
 [35]. 
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1.7  Aim of study 
The aim of this study was to develop a more sensitive, more automated, more robust 
and a simpler method than existing methods, for determination of oxysterols using LC 
MS/MS. By being able to measure the concentration of oxysterols in cancer (stem) cells, 
an increased understanding of the signal transfer methods in the Hh pathway can be 
obtained. This can be challenging due to the low number of such cells that can be 
isolated within a reasonable time. By increasing our understanding of cancer stem cells, 
new tools to stop tumor growth may be developed. 
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2 Experimental 
2.1  Materials and reagents 
Type 1 water (Milli-Q ultrapure water purification system, Millipore, Billerica, MA, US) 
was used to dilute standards and reagents and to prepare mobile phases in mixtures 
with formic acid (FA, Fluka, Sigma Aldrich, St.Louis, MO, US) and acetonitrile gradient 
grade for LC (ACN, Merck, Dramstadt, Germany). Cell lysate samples and fetal bovine 
serum (FBS) were obtained from Oslo University hospital (Oslo, Norway). 
 
2.2  Samples and standards 
Stock solutions, consisting of 200 µM of each hydroxycholesterol, 20α 
hydroxycholesterol (20αHC), 22S hydroxycholesterol (22SHC), 25 hydroxycholesterol 
(25HC) (all obtained from Sigma) and 24S hydroxycholesterol (24SHC) (Avanti Polar 
Lipids Inc) were made by dissolving 2 mg standard in 25 mL 2-propanol (Rathburn 
Chemicals LTD, Walkerburn, Scotland, UK).  
A stock solution of cholesterol (13 mM) was prepared by dissolving 125 mg cholesterol 
(Sigma) in 25 mL 2-propanol. A stock solution, 600 µM, of cholesterol 25,26,27 13C 
(CH13C) (Sigma) was prepared by dissolving 6 mg in 25 mL 2-propanol. 
25 hydroxycholesterol 26,26,26,27,27,27 d6 (25d6HC) (CDN Isotops, Quebec, Canada) 
was used as internal standard. Stock solution, 200 µM, was prepared by dissolving 2 mg 
standard in 25 mL 2-propanol. 
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These stock solutions were used to make standard and calibration solutions of different 
concentration by appropriate dilution with 2-propanol. 
Phosphate buffer, 50 mM pH 7, was prepared by dissolving 679 mg KH2PO4 (Fluka, 
Sigma Aldrich) in 100.0 mL type 1 water. 
Standards were oxidized and derivatized as described below. A schematic figure 
comparing sample preparation and preparation of standards described in the following 
chapters are shown in Figure 14. The relationship between pmol of added standard and 
final concentration in standard solutions and the injected amount on the column is 
shown in Table 1. 
 
Table 1 Amount (pmol) analyte added to the standard solutions together with concentration in standard solutions 
after derivatization, and the injected amount on column. 
 
 
 
pmol analyte 
standard 
added 
Concentration in 
standard solutions 
after derivatization 
(nM) 
Injected amount 
(pg) (injection 
volume 100 µL) 
0.2 0.3 12 
0.6 0.8 32 
0.9 1.2 48 
1.2 1.6 64 
1.6 2.1 85 
6.1 8.2 330 
12.2 16.5 664 
18.3 24.7 995 
24.3 33 1325 
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2.2.1 Preparation of cell lysate samples 
All preparation of cell lysate samples described in this chapter were performed by 
Martin Strand and Anders Grimsmo at Oslo University hospital. The different cell lines 
are described in Table 2. NIH3T3, SHh-LII, SUFU-/- and HEK293 cell lines were grown in 
Dulbecco's Modified Eagle Medium (DMEM) glutamax medium (Invitrogen, Carlsbad, 
CA), while HCT15, HCT116 and SUIT-2 were grown in RPMI 1640 medium (Sigma). For 
normal propagation the medium was supplemented with 10 % fetal bovine serum (FBS) 
and a penicillin/streptomycin (pen/strep) solution. Prior to analysis the cells were grown 
for 1 week in medium containing 1 % FBS and split into triplicates in 25cm² flasks. After 
reaching approximately 80 % confluence, the cells were trypsinated and pelleted by 
centrifugation. The cell pellet was resuspended in 200 or 400 µL ice cold lipid extraction 
solvent (Ethanol +200nM CH13C) depending on pellet volume, and samples were 
pipetted vigorously and transferred directly to a freezer (-20 °C). Samples were allowed 
to reach room temperature before subjected to the sample preparation described 
below. 
 
Table 2 Description of the different cell lines. 
Cell line Description 
NIH3T3 Fibroblast cell line from mouse embryo tissue (mouse) 
Shh-LII A clonal NIH3T3 incorporated with GLI-dependent firefly luciferiase (mouse) 
SUFU -/- Suppressor of fused (mouse) 
HEK293 Human embryonic kidney cell 
HCT15 Human colon carcinoma 
HCT116 Human colon carcinoma 
Suit 2 Human pancreatic cancer cell line 
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2.2.2 Oxidation with cholesterol oxidase 
Standards/samples were each mixed with 5 µL of 1.5 µM internal standard (25d6HC) (7.5 
pmol) and evaporated into dryness on a SC110 Savant Speed Vac. The standard/sample 
was resolved in 20 µL 2-propanol and 200 µL phosphate buffer. Subsequently, 3 µL of 
cholesterol oxidase (2 mg/mL, Sigma Aldrich) were added to the solution and the 
mixture was vortexed for 30 seconds. The reaction was carried out at 37 °C for one 
hour. 
 
2.2.3 Derivatization into Girard T or Girard P hydrazine 
After incubation, a mixture of 15 mg Girard T (Sigma) or Girard P (TCI Europe, 
Zwijndrecht, Belgium) reagent, 15 µL glacial acetic acid (Merck) and 500 µL methanol 
(MeOH, VWR, West Chester, PE, US) were added to the oxidized mixture. The 
derivatization reaction was carried out in the dark overnight. Total final sample volume 
was 740 µL. Sample clean-up to remove excess reagent was performed either on-line or 
off-line, the latter only in the preliminary experiments. 
 
2.2.4 Off-line sample clean-up to remove excess reagent 
A recirculation procedure was used as described by Griffiths et al [8] in early stages of 
this study.  
A 200 mg Varian Bond Elute LRC C18 SPE (Varian Inc, Palo Alto, CA, US) was 
preconditioned with 6 mL MeOH, 6 mL 10 % MeOH and 6 mL 70 % MeOH. The standard 
or sample (3mL) in 70 % MeOH was loaded on the SPE and the eluate was collected in a 
10 mL vial. The sample vial was washed with 1 mL 70 % MeOH and this washing solution 
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was loaded on the SPE. The eluate was collected in the same 10 mL vial. The SPE was 
washed with 1 mL 35 % MeOH and this eluate was collected in the same 10 mL vial. The 
eluate was diluted with 4 mL type 1 water, generating a total of 9 mL 35 % MeOH 
solution. This solution was reloaded on the SPE column and the new eluate was 
collected in a 25 mL vial. The SPE column was subsequently washed with 1 mL 17 % 
MeOH and the eluate was collected in the same 25 mL vial as the eluate from the 
sample. 9 mL type 1 water was added to the eluate, to give approximately 19 mL of a 17 
% MeOH solution. This solution was again reloaded on the SPE column. The SPE column 
was finally washed with 6 mL 10 % MeOH. To elute derivatized oxysterols from the SPE 
column, 2-4 aliquots of 2 mL MeOH was used.  
 
2.2.5 On-line sample clean-up to remove excess reagent 
In later stage of this study, an on-line approach was used; by applying the robust 
automatic filtration and filter flush (AFFL)-SPE system described in chapter 1.4.2, sample 
clean-up was automated and carried out in the same instrument as the LC MS/MS 
analysis. An aliquot of 100 µL sample or standard solution was loaded on a 1 mm i.d. x 5 
mm HotSep Tracy Kromasil C18 column (5 µm, 100Å) obtained from Teknolab (Kolbotn, 
Norway) after an on-line filtration through a 1 µm stainless steel filter (Valco 
Instruments, Huston, TX, US). Injection was performed by an Agilent G1313A ALS auto 
sampler (Palo Alto, CA, US) and a Hitachi L-7110 pump (Merck) was used as a loading 
pump. Flow rate was set to 300 µL/min. To wash out excess Girard reagent, loading time 
was set to 2.5 minutes and FA/H2O (0.1/99.9, v/v) was used as a mobile phase. When 
the valve was switched, an Agilent 1200 series analytical pump with flow rate of 75 
µL/min eluted the analytes from the trap column to a 1 mm i.d. x 150 mm ACE C18 
analytical column (3µm, 100Å) (Advanced Chromatography Technologies, Aberdeen, 
SD). Both trap column and analytical column were placed in an oven at 45 °C.  
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Derivatized oxysterols were separated isocratically using a mobile phase consisting of 
FA/H2O/ACN (0.1/45/55, v/v/v). An additional washing step with FA/H2O/ACN (0.1/5/95, 
v/v/v) was included after 10.5 minutes to wash out more hydrophobic compounds in 
the sample. Re equilibration time was 3 minutes. 
A Knauer D-14163 pump (Berlin, Germany) was used to back-flush the filter automatic 
with FA/H2O (0.1/99.9, v/v) while the analysis was running. 
 
2.2.6 Sample preparation of medium with fetal bovine serum 
(FBS) 
First, 100 µL medium containing FBS was filtrated through a Millipore Amicon 0.5 mL 
10K (Millipore, Billerica, MA, US) spin filter to remove proteins. The medium was diluted 
with 100 µL 50 mM phosphate buffer pH 7 after filtration. Secondly, 10 µL 2-propanol 
was added to the sample, and oxidation and derivatization were performed as described 
in chapter 2.2.2 and 2.2.3.  
Spiked medium samples were prepared by spiking medium with 10 µL 12 µM 20αHC, 
22SHC and 25HC before sample preparation. This gives a spiked concentration of 174 
nM 20αHC-GT, 22SHC-GT and 25HC-GT in the derivatized sample. 
 
2.2.7 MS and MS/MS detection 
The analytical column was connected to an Esquire 3000+ IT MS with a capillary 
electrospray ionization source (Bruker Daltonics, Billerica, MA, US). Ionization was 
performed in positive mode with a capillary voltage of 3500 V and skimmer voltage of 
40.0 V. Capillary exit was operated at 128.5 V. Drying gas and nebulizer gas were applied 
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at 7.0 L/min and 30.0 psi, respectively. Data were collected with an m/z range of 200-
1500 in MS mode and 400-550 in MS/MS mode using Esquire control software version 
3.5 from Bruker Daltonics. 
When the instrument was operated in MS mode, m/z 514.4 was used to monitor Girard 
T derivatives of 20α hydroxycholesterol (20αHC-GT), 22S hydroxycholesterol (22SHC-
GT), 24S hydroxycholesterol (24SHC-GT) and 25 hydroxycholesterol (25HC-GT). m/z 
534.4 was used to monitor the corresponding Girard P derivatives.  When sample clean-
up was performed on-line, only Girard T derivatives of the oxysterols were used. To 
monitor Girard T derivatives of the internal standard, 25 hydroxycholesterol 
26,26,26,27,27,27 d6 (25d6HC-GT) in MS mode, m/z 520.4 was used. 
In MS/MS the instrument was operated in MRM mode. Analytes with a neutral loss of 
59 Da was re-trapped and the intensity measured. The m/z values monitored for each 
derivatized oxysterol are shown in Table 3. For monitoring autoxidation during sample 
preparation, the mass for 13C labeled derivatized oxysterol (13C-HC-GT) was used.  
 
Table 3 Monitored oxysterol, internal standard and autoxidation control m/z values in MS and MS/MS mode. 
Analyte m/z MS mode Fragmentation m/z MS/MS mode 
20αHC-GT 514.4 514.4→455.4 455.4 
22SHC-GT 514.4 514.4→455.4 455.4 
25HC-GT 514.4 514.4→455.4 455.4 
24SHC-GT 514.4 514.4→455.4 455.4 
25d6HC-GT 520.4 520.4→461.4 461.4 
13C-HC-GT 517.4 517.4→458.4 458.4 
 
2.2.8 Quantification 
To quantify the oxysterols in samples, a calibration curve was constructed using linear 
regression in Microsoft Excel. The calibration curves were created by plotting the ratio 
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of analyte area and internal standard area as a function of the ratio between analyte 
concentrations and internal standard concentration. Calibrations solutions were made 
as described for standard solutions in chapter 2.2.2 and 2.2.3. Concentrations used for 
calibration were as shown for standard solutions in Table 1. Integration of peak area 
was performed using Esquire control software version 3.5. In MRM mode, the Extracted 
ion chromatogram (EIC) was smoothened before integration.  
 
2.2.9 Nuclear magnetic resonance (NMR) analysis 
13C NMR analysis was performed on 20α hydroxycholesterol by Frode Rise (Department 
of Chemistry, University of Oslo) on a Bruker Avance II 400 instrument. 5 mg of 20α 
hydroxycholesterol were dissolved in DMSOd6 (Cambridge Isotope Laboratories, MA, 
US). 
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Figure 14 Schematic view of sample preparation and standard solution preparation. 
Celle lysate (in Ethanol, Volume:200-400 µL) 
Addition of internal standard (7.5 pmol) 
Evaporation into dryness 
Resolve in 20 µL 2-propanol and 200 µL 
phosphate buffer 
Oxidation with 3 µL 2 mg/mL cholesterol 
oxidase 
Derivatization with 500 µL MeOH, 15 µL 
glacial acetic acid and 15 mg Girard T reagent.  
Over night, in darkness at room temperature  
740 µL derivatized sample 
injection volume 100 µL 
AFFL-SPE-LC-MS/MS 
Standard solution containing 20αHC, 25HC, 
22SHC and 24SHC 
Addition of internal standard (7.5 pmol) 
Evaporation into dryness 
Resolve in 20 µL 2-propanol and 200 µL 
phosphate buffer 
Oxidation with 3 µL 2 mg/mL cholesterol 
oxidase 
Derivatization with 500 µL MeOH, 15 µL 
glacial acetic acid and 15 mg Girard T reagent.  
Over night, in darkness at room temperature  
740 µL derivatized sample 
injection volume 100 µL 
AFFL-SPE-LC-MS/MS 
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3  Results and discussion 
The method was developed pursuing large robustness and less sample preparation and 
sample handling compared to earlier methods, in particular the established 
methodology by Griffiths et al. [27]. In general, the oxidation step in the sample 
preparation procedure is the same as used by Griffiths et al. However, in the 
derivatization step, the Girard T reagent was preferred over the Girard P reagent, as 
derivatives of Girard P reagent were shown to be difficult to elute from the SPE column 
during sample clean-up (See 6.1.1 preliminary experiments in appendix). An on-line 
method for sample clean-up was developed, to make the method more robust and less 
time consuming.  
Column dimensions of 1-2.1 mm i.d. were initially considered because of their higher 
robustness regarding clogging, compared to capillary columns. These dimensions will 
give a less sensitive method than capillary columns, but robustness was in stronger 
demand than sensitivity in the present study.  
 
3.1  Method development 
3.1.1 Separation of isomers 
The oxysterol isomers 20αHC-GT, 22SHC-GT, 25HC-GT and 24SHC-GT share the same 
molecular mass, mass fragmentation, and have similar chemical properties (e.g. log P). 
Since these oxysterols however, may have different biological functions, an effective 
separation step is essential for correct quantification of the individual isomers. In 
addition, a fast separation method (time limit of 20 min) was preferred. Different 
commercial available columns 2.1 mm to 1 mm i.d. with different carbon load were 
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initially tested (Table 4). In addition, a ZIC HILIC (Sequant ZIC®HILIC, i.d. 1 mm, 150 mm, 
3.5 µm, 100Å) column was investigated. However, separation was not achieved with 
HILIC. 
 
Table 4 Columns investigated in preliminary experiments. 
Column Phase Dimensions Particle size Pore size Surface 
area 
Carbon 
load (%) 
Waters Acquity 
UPLC HSS T3 
C18 2.1 mm i.d. x 
100 mm 
1.8 µm 100 Å 230 11 
Waters Acquity 
UPLC BEH 
C18 2.1 mm i.d. x 
50 mm 
1.7 µm 130 Å 185 18 
Advanced 
chromatography 
technologies 
ACE 3  
C18 1 mm i.d. x 
150 mm 
3 µm 100 Å 300 15.5 
 
 
Sufficient separation was not achieved in the preliminary experiments using Waters 
Acquity UPLC BEH or Waters Acquity UPLC HSS T3 columns. Chromatograms using the 
Waters Acquity UPLC HSS T3 column are shown in Figure 15. The ACE 3 C18 column 
provided sufficient selectivity to separate the isomers under similar conditions (Figure 
16). This column was used in the further method development. The column had a 
constant pressure during the whole method development, evaluation and cell sample 
analysis and did not need to be changed during this study (about 2600 injections).  
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Figure 15 EIC (m/z 514.4) of a) 1.7 µM Girard P derivatives of 20αHC, b) 1.6 µM Girard P derivatives of 25 HC and c) 
2.2 µM Girard P derivatives of 22SHC chromatographed on a Waters Acquity UPLC HSS T3 C18 column, using a 
mobile phase consisting of FA/H2O/ACN (0.1/25/75, v/v/v) at 50 µL/min. Injection volume was 10 µL. Sample 
clean-up was performed off-line, using the recirculation procedure described in chapter 2.2.4. 
1
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Figure 16 EIC (m/z 514.4) of a) 1.7 µM Girard P derivatives of 20αHC, b) 1.6 µM Girard P derivatives of 25HC and c) 
2.2 µM Girard P derivatives of 22SHC chromatographed on an ACE C18 column. Chromatographic conditions as 
described in Figure 15.
2
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3.1.2 Effects of temperature and wash out step 
During method development, effects of temperature were studied. Analysis of standard 
solutions containing 8 nM 25 HC-GT, 20α HC-GT and 22SHC-GT at 25 °C, 35 °C and 45 °C 
with a flow rate of 50 µL/min are shown in Figure 17. As seen from the figure, a higher 
temperature gives narrower peaks, without destroying chromatographic selectivity. In 
addition, a higher temperature allows a higher flow rate without increasing the 
backpressure or plate height compared to room temperature and standard flow rate. 
The flow rate could be increased from 50 µL/min to 75 µL/min. Hence analysis time was 
shortened. A temperature of 45 °C on both column and trap column together with a 
flow rate of 75 µL/min on column and 300 µL/ min on trap column were therefore used 
in this method. 
A washing step was also included in the method to wash out more hydrophobic 
compounds in the samples from the column. When applying the washing step after 
separation, a system peak appears in the chromatograms for both standards and 
samples. In general, employing more than 65 % ACN in the mobile phase reduced the 
intensity of this additional system peak, which appeared after the derivatized oxysterol 
isomers. It is possible that this peak is a result of secondary interaction of the 
derivatized oxysterols on the column. This peak is further discussed in appendix 6.2 . 
However, the presence of this additional peak did not affect the relation between the 
analytes and the labeled internal standard used for quantification. 
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Figure 17 EIC (m/z 514.4) of 8 nM 20αHC-GT, 25HC-GT and 22SHC-GT chromatographed on a ACE C18 column, using 
a mobile phase consisting of FA/H2O/ACN (0.1/40/60, v/v/v) at 50 µL/min. After 12.5 minutes a washing step was 
applied (FA/H2O/ACN (0.1/5/95, v/v/v)). Temperatures were set to 25 °C (a), 35 °C (b) or 45 °C(c). Injection volume 
was 100 µL and sample clean-up were performed on-line using AFFL-SPE. Loading mobile phase and filter back-
flush solution consisted of FA/H2O (0.1/99.9, v/v). Loading and washing time were set to 5 minutes with a flow rate 
of 150 µL/min and the filter was back-flushed with a flow rate of 300 µL/min.  
 
 
3.1.3 Internal standard 
Since the sample preparation contains several steps where analyte can be lost, and to 
correct for MS variations, an internal standard was included in the method. When MS is 
used, the opportunity for using an almost ideal internal standard, an isotope-labeled 
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analyte is possible. In this method 25 hydroxycholesterol 26,26,26,27,27,27 d6 was 
chosen as an internal standard. Separation of all analytes in a standard solution together 
with the internal standard is shown in Figure 18. 
 
 
Figure 18 EIC (m/z 455.4, analytes) and EIC (m/z 461.4, internal standard) for a standard solution containing 1.2 nM 
25HC-GT, 24SHC-GT, 20αHC-GT and 22SHC-GT together with 10 nM 25d6HC-GT as an internal standard 
chromatographed on a ACE C18 column, using a mobile phase consisting of FA/H2O/ACN (0.1/45/55, v/v/v) at 75 
µL/min. After 10.5 minutes a washing step was applied (FA/H2O/ACN (0.1/5/95, v/v/v). Temperature was 45 °C and 
injection volume was 100 µL. Sample clean-up was performed on-line using AFFL-SPE. Loading time was set to 2.5 
minutes with a flow rate of 300 µL/min. 
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3.1.4 Final separation conditions 
Best performance and separation on the column were found using an isocratic elution 
with a mobile phase consisting of FA/H2O/ACN (0.1/45/55, v/v/v) followed by a washing 
step with FA/H2O/ACN (0.1/5/95, v/v/v). Sample clean-up was performed on-line on an 
AFFL-SPE system. Development of sample preparation method and sample clean-up is 
discussed in following chapters. The temperature on analytical column and trap column 
was set to 45 °C, and the flow rate was set to 75 µL/min for the analytical column. Flow 
rate on the trap column was set to 300 µL/min and the mobile phase consisted of 
FA/H2O (0.1/99.9, v/v). These conditions allows sample clean-up and separation of 
25HC-GT and 24SHC-GT in 7 minutes. Separation of these isomers by RP LC has 
previously been described as difficult [9]. EIC (m/z 514.4) for each analyte (20αHC-GT, 
25HC-GT, 24SHC-GT and 22SHC-GT) together with EIC (m/z 455.4, MS/MS mode) for a 
mixture consisting of all four analytes are shown in Figure 19 and Figure 20.  
At these conditions, separation, wash and re equilibration within the time limit of 20 
minutes was achieved. Total run time was set to 16 minutes including the on-line 
sample clean-up.  
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Figure 19 EIC from MS mode (m/z 514.4) of a) 35 nM 20αHC-GT, b) 31nM 25 HC-GT, c) 21nM 22SHC-GT and d) 13 
nM 24SHC-GT. Chromatographic conditions as described in Figure 18.  
 
As seen from chromatogram in Figure 19 a, the 20αHC-GT isomer appears as two peaks. 
13C NMR experiments (see appendix, chapter 6.3) implied that this oxysterol standard is 
a mixture of stereo isomers, which can partly explain the broadness and peak splitting, if 
the stereo isomers have differences in retention factors on the column employed. Such 
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(stereo) isomeric mixture of related compound has been observed previously [36]. 
20αHC-GT was not observed in any of the examined cell lysate samples, and was 
therefore not included in the validation of the method.  
 
 
Figure 20 EIC from MS/MS mode (m/z 455.4) of a mixture of 1.9 nM 20αHC-GT, 25HC-GT, 22SHC-GT and 24SHC-GT. 
Chromatographic conditions as described in Figure 18.  
 
3.1.5 On-line vs. off-line sample clean-up 
Preliminary experiments showed poor repeatability of analysis of standard solutions. 
This issue was soon addressed to the sample clean-up procedure, as it was shown 
difficult to elute all derivatized oxysterols from the off-line SPE (appendix 6.1.1). By 
applying an AFFL column switching system, and using the trap column as an SPE, the 
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repeatability was improved (Figure 21 and Figure 22). Relative standard deviation (RSD) 
was found to be between 55 and 61 % for the off-line sample clean-up compared to 
between 3 and 9 % for the on-line sample clean-up. The on-line sample clean-up with 
AFFL-SPE technique was therefore used in this method. During the method 
development, validation and the analysis of samples the trap column was changed twice 
(about 2600 injections). The filter was also used by other operators on various samples 
during the time of this study and was changed once during the method development. 
 
 
Figure 21 EIC (m/z 455.4, n=3) for a standard solution containing 49 nM 25HC-GT, 20αHC-GT and 22SHC-GT 
chromatographed on a ACE C18 column, using a mobile phase consisting of FA/H2O/ACN (0.1/30/70, v/v/v) at 50 
µL/min. Injection volume was 20 µL. Sample clean-up was performed off-line as described in chapter 2.2.4. RSDs 
(%) were 55, 61 and 61 % for 25HC-GT, 20αHC-GT and 22SHC-GT, respectively.  
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Figure 22 EIC (m/z 455.4, n=3) for a standard solution containing 118 nM 25HC-GT, 20αHC-GT and 22SHC-GT.  
Sample clean-up was performed on-line using AFFL-SPE system. Loading mobile phase and filter back flush solution 
consisted of FA/H2O (0.1/99.9, v/v). Loading and washing time were set to 5 minutes with a flow rate of 150 
µL/min and the filter was back flushed with a flow rate of 300 µL/min. All other chromatographic conditions as 
described in Figure 21. RSDs (%) were 3, 7 and 9 % for 25HC-GT, 20αHC-GT and 22SHC-GT, respectively.  
 
3.1.6 Column switching with and without AFFL  
A common concern with column switching is clogging of the columns. About 35 cell 
lysate samples were injected on a normal column switching system and on an AFFL-SPE 
system. Loading pump back-pressure was monitored and the results are shown in Figure 
23. Even after 35 injections on the AFFL system, the backpressure was steady, compared 
to the column switching system without the filter and filter flush where backpressure 
increased with ~ 50 bar after 10 injections. 
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Figure 23 Pressure (bar) over trap column vs. injection number, with and without AFFL in the SPE-LC instrument. 
 
 
3.1.7  Recovery on AFFL Filter 
To make sure no analyte was lost in the filter in the AFFL system, a recovery experiment 
was conducted. A standard (n=3) was injected on the system with and without the filter. 
Recovery was found to be 98 % or higher for all analytes, including the internal 
standard. No analytes are lost in the AFFL system. 
 
3.1.8 Carry over 
Another common concern with column switching techniques is carry over [37, 38]. Carry 
over can affect accuracy and precision of the method. Carry over can occur by 
adsorptive interactions anywhere in the system, including the injector. By using a trap 
column, more tubing is induced which, in addition to adsorption of analyte on the trap 
0 
20 
40 
60 
80 
100 
120 
140 
160 
180 
200 
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 
Pressure 
(bar) 
Injection number 
With AFFL 
Without AFFL 
55 
 
column can give more carry over. Possible carry over were checked by a blank injection 
(100 µL FA/H2O/ACN, 0.1/45/55, v/v/v) after samples. Minimal carry over was found in 
the system, as shown in Figure 24 . On some occasions, after an injection of high 
concentration (33nM) some carry over (>1 %) was observed. This was remedied by one 
blank injection after high concentration solutions and samples. 
 
 
Figure 24 EIC (m/z 455.4) for a) 100 µL HTC116 cell lysate sample and b) 100 µL blank sample. Chromatographic 
conditions as described in Figure 18.  
 
 
3.1.9 SPE breakthrough 
Breakthrough on SPE columns can occur if the standard or sample is dissolved in a 
solvent with high elution strength. For example, a high MeOH concentration can cause 
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elution of analytes from the SPE during the loading and washing cycles. On the other 
hand, solubility issues of the derivatized oxysterols may occur if the MeOH 
concentration is too low. Since the derivatization reaction is performed in a strong 
solvent (67 % MeOH) and this sample is preferably injected on to the SPE system to 
have a simpler sample preparation, a study of breakthrough was performed.  
As seen in Figure 25, breakthrough appeared when the concentration of MeOH was 
around 70-75 % in the injected sample. Hence, the reaction solution containing 67 % 
MeOH was possible to inject directly. Also, when MeOH concentration was below 55 %, 
peak area decreased. This can be explained by poor solubility of the oxysterols in low 
concentrations of MeOH.  
 
Figure 25 Peak area of each analyte as a function of the concentration of MeOH in the sample. Chromatographic 
conditions as described in Figure 17 at room temperature. 
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3.1.10 Oxysterols in medium with Fetal Bovine Serum (FBS) 
Medium with FBS is used at Oslo University Hospital to grow cell samples. Analysis, 
including sample preparation of medium containing FBS, was performed to ensure that 
no analytes were present in the medium. As the medium contains large amounts of 
proteins, these were initially removed using a spin filter with a cut off of 10K. Larger 
proteins should be retained by the filter, while small molecules, like oxysterols should 
flow through. However, no oxysterols were found in highly spiked medium samples, 
indicating that this procedure was not successful for recovering the oxysterols. Removal 
of proteins with spin filters apparently also removed oxysterols, probably due to binding 
between oxysterols and proteins.  
Spiked and unspiked medium samples were therefore prepared without removal of 
proteins on spin filters and the resulting chromatograms from LC MS/MS analyses are 
shown in Figure 26.  The spiked sample was added 20αHC, 22SHC and 25HC to give a 
final spiked concentration of 190 nM. All three oxysterols were identified in the sample, 
implying that the method could be used without removal of proteins with spin filters. In 
the unspiked sample, all three analytes were also identified, implying that the medium 
contains oxysterols. This fact will make quantification of oxysterol in cell lysate samples 
difficult, as it is impossible to determine how much of the oxysterols originate from the 
medium and how much is produced by the cell.  To avoid this problem, the cells need to 
be cultivated in media free of oxysterols. However, this makes cultivation of the cells 
challenging, as the cells need nutrition to grow. This issue was solved by adding only 1 % 
FBS in the medium. Medium control samples were therefore included in the analyses 
series of cell samples. No oxysterols were found in the medium control samples, 
implying that the oxysterol concentration in 1 % FBS medium was under limit of 
detection (LOD) for the method.  
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Figure 26  EIC (m/z 455.4) for a) FBS medium and b) FBS medium spiked with 190 nM 25HC-GT, 20αHC-GT and 
22SHC-GT. Chromatographic conditions as in Figure 17 at room temperature.  Insert shows an enlargement of the 
oxysterols found in the FBS medium. 
 
 
3.2 Method evaluation 
3.2.1 Selectivity 
A selective method is important to quantify analytes without interferences from other 
components in the sample. By applying a MS/MS method, the method is made selective 
for detection of oxysterols. Only molecular ions with the same mass and fragmentation 
ion as the analytes are detected in the MS.  
Ideally, blank samples from similar matrix should be analyzed to determine if any 
interferences are present. However, cell lysates without analytes are not available. 
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Selectivity considerations were therefore performed by comparing standards and cell 
lysate samples in MS mode. No other components with the same mass and 
fragmentation pattern as the oxysterol derivatives were observed in the samples or 
standards. The method is selective for oxysterol derivatives. 
When applying ESI, ion suppression might be an issue. If large amounts of more easily 
ionizable components in the sample/standard elute with the same retention time as the 
analyte, analyte ions may be suppressed. As shown in MS chromatogram of Suit 2 cell 
lysate (Figure 27), no other components were detected in significant concentrations in 
the MS at the same retention time as the analytes. Ion suppression should therefore not 
be an issue in the method 
 
 
Figure 27 Total ion chromatogram (TIC) for Suit 2 cell lysate. Chromatographic conditions as described in Figure 18.  
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Oxysterols, as being oxidation products of cholesterol can be subjected to autoxidation. 
This procedure may create false results in the analysis. 25,26, 27 13C cholesterol (Sigma) 
was used as an autoxidation internal standard of cholesterol. By addition of this 
autoxidation internal standard to the sample, autoxidation during sample preparation 
can be revealed. The standard was (200 nM) was added to the cells, so autoxidation 
during the whole procedure could be monitored. Autoxidation product formation was 
found to be minimal (Figure 28) and hence did not need be considered. 
 
 
Figure 28 a) EIC (m/z 455.4) and b) EIC (m/z 458.4, monitoring for autoxidation) for HCT116 cell lysate. 
Chromatographic conditions as described in Figure 18.  
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3.2.2 Limit of detection (LOD) and limit of quantification (LOQ) 
Limit of detection (LOD) was defined in this study as the concentration amount which 
gave a signal to noise ratio (S/N) of three or higher. With this criterium, 0.06 nM and 2.5 
pg injected on the column were found to be cLOD and mLOD in single reaction monitor 
(SRM) mode, respectively (Figure 29). This corresponds to 44 fmol analyte on column. 
Below 0.06 nM, only noise was observed.  
 
 
Figure 29 EIC (m/z 455.4) of 0.06 nM 25HC-GT, 20αHC-GT and 22SHC-GT. Chromatographic conditions as described 
in Figure 17.   
 
When determining the limit of quantification, the MS was operated in MRM mode, 
monitoring both fragment ion from analyte and internal standard, in addition to 
0 2 4 6 8 10 12 Time [min]
0
500
1000
1500
2000
2500
Intens.
25HC-GT 
20αHC-GT 
22SHC-GT 
62 
 
monitoring fragment ion from autoxidation. When the Esquire 3000 + IT MS is operated 
in MRM mode, measuring on several fragmentation patterns, the sensitivity is reduced 
relative to SRM mode because the IT MS measures only one fragmentation reaction at 
the time. 
 LOQ is defined as the lowest amount of the analyte that can be quantitatively 
determined with a suitable precision and accuracy (RSD 20 %). This level was found at 
0.3 nM or 15 pg injected on the column. This corresponds to 22 pmol analyte injected. 
Both the LOD and LOQ levels were found acceptable for the method when using a 
narrow bore column. The LOD is higher than previously published methods by Karu et al 
(400 fg on column [28]). However, in that method, a capillary column was used (i.d. 180 
µM). By applying a capillary column, the LOD of the AFFL-SPE-LC-MS/MS method can be 
improved.  
Honda et al [1] have presented a method with good detection limits on a narrow bore 
column (i.d. 2.1 mm, 5-10 fg on column). In their method, oxysterols are derivatized into 
picolinyl esters before LC MS/MS analysis. However, the derivatization reaction involves 
incubation at 80 °C for one hour followed by an evaporation of solvents at 80 °C. At this 
temperature, autoxidation can occur. Without any monitoring of autoxidation in the 
sample, the identification and quantification of oxysterols with this method may be less 
accurate.  
 
3.2.3 Linearity range for oxysterol standard solutions 
The linearity range for the method was validated in the concentration range from 0.3 to 
33 nM. The linearity curves for 25HC-GT, 24SHC-GT and 22SHC-GT are shown in Figure 
30. Data were obtained by single injection of 6 prepared replicates at each 
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concentration level. The method showed good linearity over a large area of 
concentration with R2> 0.99 for all three analytes.  
 
Figure 30 Total method linearity curves in the range from 0.3 nM to 33 nM for 25HC-GT, 24SHC-GT and 22SHC-GT. 
Chromatographic conditions as described in Figure 18. Data was obtained by single injection of 6 prepared 
replicates at each concentration level.  
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3.2.4 Repeatability 
Repeatability was study for standard solutions containing oxysterols at three levels: low 
(0.3 nM), medium (2.1 nM) and high (33 nM), both between days (n=5) and within day 
(n=6). Between days repeatability were determined by preparing and analyzing new 
standard solutions on five days. Within day (between replicates) repeatability were 
determined by preparing and analyzing six different standard solutions the same day. 
Results are shown in Table 5. For the internal standard RSD was found to be 10 % 
between replicates (n=12) and 6 % between days (n=5), which is satisfying for the 
method. Calculation and statistic are shown in appendix (chapter 6.4). 
Table 5 Repeatability in standard solutions, between replicates and between days. 
 25 hydroxycholesterol (nM) n RSD (%) 
Between replicates 0.3 6 19 
2.1 6 5 
33 6 5 
Between days 0.3 5 6 
2.1 5 9 
33 5 5 
 24S hydroxycholesterol (nM) n RSD (%) 
Between replicates 0.3 6 15 
2.1 6 6 
33 6 6 
Between days 0.3 5 16 
2.1 5 9 
33 5 9 
 22S hydroxycholesterol (nM) n RSD (%) 
Between replicates 0.3 6 16 
2.1 6 13 
33 6 5 
Between days 0.3 5 12 
2.1 5 12 
33 5 8 
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The between replicates results were found acceptable for the method. As expected, 
highest RSDs were found at the lowest concentration level, near the LOQ. At this 
concentration level, the peaks were low and difficult to integrate. The between days 
repeatability were good, implying that the method is robust.   
 
3.2.5 Recovery in spiked cell lysate samples 
The found concentration of analysis in cell lysate samples spiked with 25HC and 22SHC 
at three concentration levels (4.1 nM, 8.1 nM and 12.2 nM) were compared with that of 
standard solutions spiked with the same concentrations. Recoveries were found to be 
109 and 105 % for 25HC-GT and 22SHC-GT, respectively. Recovery was calculated by 
using linear regression and according to the formula: 
         
 
 
      
where a and b is the regression line slope for the spiked cell lysate and the standard 
solutions, respectively. The curves are shown in Figure 31. 
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Figure 31 Linearity curves for calculation of recovery in spiked cell lysate samples. Chromatographic conditions as 
described in Figure 18. 
 
 
y = 59044x - 32271 
y = 64466x + 38241 
0 
100000 
200000 
300000 
400000 
500000 
600000 
700000 
800000 
900000 
0 5 10 15 
Area 
Concentration (nM) 
25 hydroxycholesterol 
standard solutions 
spiked cell lysate 
y = 141477x - 142525 
y = 148883x - 36299 
0 
200000 
400000 
600000 
800000 
1000000 
1200000 
1400000 
1600000 
1800000 
2000000 
0 5 10 15 
Area 
Concentration (nM) 
22S hydroxycholesterol 
standard solutions 
Spiked cell lysate 
67 
 
3.3 Determination of oxysterols in cell lysate 
Cells cultivated in 1 % FBS s were prepared at the Oslo University Hospital by Martin 
Strand and Anders Grimsmo. Different cell lines were analyzed, to find cell lines which 
should be used to further study the interplay between oxysterols and Hh pathway. A 
representative chromatogram (EIC (m/z 455.4)) of HEK293 cell line analysis is shown in 
Figure 32.  
 
 
Figure 32 EIC (m/z 455.4) of derivatized HEK293 cell lysate. Chromatographic conditions as described in Figure 18. 
The content of one cell flask was analyzed.  
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identification in a later study. The identified oxysterols in various cell line samples are 
shown in Table 6.  
 
Table 6 Identified oxysterols in various cell line samples. 
Cell 25 
hydroxycholesterol 
24S 
hydroxycholesterol 
22S 
hydroxycholesterol 
Sufu (Mouse) X X  
SHh-LII (Mouse) X X X 
3T3 (Mouse) X X X 
HEK293 (Human) X X X 
HCT15 (Human) X X X 
HCT116 (Human) X X X 
 
Quantification of the concentration of oxysterols in the cell samples is difficult, since the 
cells were not counted before they were prepared. Instead, the concentration in pg per 
cell flask was calculated.  These results are shown in Table 7, while a graphic 
presentation is given in Figure 33. The between cell-flask variation (n=3) was low 
(RSD=5-35 %, except for 24SHC in Shh-LII where RSD= 65%) implying that the method is 
robust.  
Table 7 Concentration (pg/flask) with RSD (%) of oxysterols in various cell lines (n=3 or 1(Sufu and HEK293 cell 
line)).  
Cell 25 
hydroxycholesterol 
pg/flask (RSD %) 
24S 
hydroxycholesterol 
pg/flask (RSD %) 
22S 
hydroxycholesterol 
pg/flask (RSD %) 
Sufu (Mouse) 536 >LOQ  
SHh-LII (Mouse) 279 (18) 140 (65) 300 (35) 
3T3 (Mouse) 214 (7) >LOQ 380 (9) 
HEK293 (Human) 684 1858 4644 
HCT15 (Human) 281 (16) 1371 (11) 902 (22) 
HCT116 (Human) 227 (7) 3274 (5) 846 (7) 
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These initial experiments show some trends: For all mice cells, 24SHC (the weakest Hh 
activator) was the least abundant. In contrast, 24SHC was the highest abundant in both 
of the human colon cancer cell lines (HCT15 and HCT116). In human embryonic kidney 
cells, 22SHC (the strongest SMO activator of the analytes detected, 15 times stronger 
than 24SHC [11]) was the most abundant. Hence, the varying levels of oxysterols in 
different cell lines may need to be taken in to account when assessing the effect of 
novel Hh antagonists. Similar levels of oxysterol analytes were found in the various cell 
lines, but comparison of levels between cell groups must be done with caution, due to 
the variation in cell size, morphology and growth pattern. 
 
 
Figure 33 Graphic view of oxysterols quantified in different cell lines. For all mice cell, 24SHC, the weakest Hh 
activator was the least abundant. In contrast 24SHC was the highest abundant in human colon cancer cell line 
(HCT15 and HCT116). In human embryonic kidney cells (HEK293) the strongest Smo activators of the analytes, 
22SHC was the most abundant.  
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The method was also used to analyze stem cell subpopulations and the results are 
shown in Figure 34 together with a representative chromatogram of one sample and a 
standard for identification of the analytes (Figure 35). This study was performed to 
examine if the method was sensitive enough to monitor minor sub-populations of cells 
in a cell line. For test purposes, the human pancreas adenocarcinoma cell line BxPC3 
was chosen. This cell line has documented heterogeneity, with some cells showing 
increased tumor initiating potential [39]. BxPC3 cells were sorted into vimentin positive 
(vim +) and vimentin negative (vim -) cells. Samples containing only 330 000 cells per 
population were analyzed.  Vim + cells showed significantly higher levels of the analyte 
24SHC, while the analytes 22SHC and 25HC showed little alternations. It remains to be 
seen whether the detected alterations of 24SHC in BxPC3 cells are of functional 
relevance. However, the sensitivity achieved in this method opens for future detailed 
analysis of oxysterol levels in small cell populations.  
The method was shown to be robust and it is at time of writing being modified for 
capillary columns. By using a narrower column, the method can be made more sensitive 
for analysis of small cell populations. 
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Figure 34 Concentration of 25HC, 24SHC and 22SHC in BxPC3 Vim+ and Vim – cells found using the developed 
method. 
 
Figure 35 EIC (m/z 455.4) of a) BxPC3 cell vim+ together with b) a standard (0.6 nM 25HC-GT, 24SHC-GT, 20αHC-GT 
and 22SHC-GT). Chromatographic conditions as described in Figure 18. 
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4 Conclusion 
A robust sensitive and selective method for determination of oxysterols in biological 
samples has been developed. The method is suitable for determination of oxysterols in 
cancer stem cells. By applying the AFFL-SPE-LC-MS/MS system, sample preparation and 
sample handling is kept at minimum. All sample preparation is performed in one vial. 
This reduces the possibility of sample loss during sample preparation.  
The method was applied for analysis of different cell lines, and oxysterols were 
identified in all.  Opposite expression of the 24SHC and 25HC was discovered in cell lines 
from mice and humans. The method was also successfully used for analysis of a cell 
subpopulation of 330 000 cells.  
The method can and should be made more sensitive by applying a column with a 
narrower i.d. With the AFFL-SPE system, clogging due to smaller diameter on the 
column should not be an issue. In addition, it may be possible to inject larger volumes 
even on a smaller column.  This can make the method even more sensitive.  
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6 Appendix 
6.1 Preliminary experiments 
This chapter contains results from preliminary experiments on sample preparation.  
6.1.1 Sample preparation: elution of Girard derivatives from SPE 
column 
According to literature [5] all Girard P derivatives of oxysterols should be eluted with 
2x1 mL of MeOH from the SPE. However, preliminary experiments showed that even 
after applying 4 fractions of 1 mL MeOH, Girard P derivatives of oxysterols were still 
eluting. To possibly avoid this problem, the derivatized standards could me made more 
hydrophilic using Girard T reagent. However, elution of all analytes from the SPE column 
was still difficult (Figure 36). In addition, for some of the fractions, a large peak 
appeared in the chromatogram, with shorter retention time than the analyte. Elution 
with stronger mobile phases, such as acetonitrile and dichloromethane was examined. 
However, also when using these solvents, the oxysterol derivatives eluted in several 
fractions. By using large volume to elute all analytes, a large dilution of the sample 
occurs, and an up-concentration step would be necessary to achieve good enough 
detection limits.  
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Figure 36 EIC (m/z 455.4) of 4 fractions after off-line sample preparation of 1.5 µM 20αHC-GT, 25HC-GT and 22SHC-
GT standard chromatographed on a ACE C18 column, using a mobile phase consisting of FA/H2O/ACN (0.1/30/70, 
v/v/v) at 50 µL/min. Injection volume was 10 µL and each fraction were eluted from the off-line SPE with 1000 µL 
MeOH.  
 
To avoid further dilution of the sample and not to add more steps to the sample 
preparation, an on-line approach was investigated. This also makes it possible to inject 
large volume of samples with low concentration, without excess band broadening. To 
make sure that all analytes were eluted from the trap column, a blank consisting of 
FA/H2O/ACN (0.1/45/55, v/v/v) was analyzed after analysis of standard solution (Figure 
37).  Analysis of the blank showed minimal carry over, implying that all of the analytes 
were eluted from the trap column in the on-line approach.   
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Figure 37 EIC (m/z 455.4) of a) 2.5 nM 25HC-GT, 20αHC-GT, 24SHC-GT and 22SHC-GT standard followed by b) a 
blank injection (100 µL FA/H2O/ACN, 0.1/45/55, v/v/v). Chromatographic conditions as described in Figure 18. No 
carry over was observed. 
 
 
6.1.2 Sample preparation: Amount of Girard T reagent 
To examine the effect of added Girard T reagent to standard solutions, different mol 
ratios were added to standard solutions and their MS intensity was compared. The 
different ratios that were examined are shown in Table 8. Highest intensity was 
achieved when using a mol ratio of 60 000 or more (data not shown). 
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Table 8 mol ratios of Girard T reagent. 
µmol 
analyte 
µmol Girard 
T 
Ratio (µmol GT/µmol 
analyte) 
0.012  890 74 000 
0.012 750 62 500 
0.012 600 50 000 
0.012 450 37 500 
0.012 300 25 000 
0.012 150 12 500 
 
In a 25 cm3 flask cell lysate samples contain small total amount of oxysterols and 
cholesterol (estimated 170 pmol), an addition of 15 mg Girard T (89 µmol) gives a mol 
ratio of 520 000. Hence, the amount of Girard T is excessive in the sample. The amount 
of added Girard T could probably be even lower, however handling such small quantity 
of solid is difficult (e.g. weighing).  
 
6.1.3 Effects of cholesterol on sample preparation 
Preliminary studies with cholesterol added to standard solutions were preformed to 
examine of cholesterol in standards and samples affects the sample preparation. 
Cholesterol will be oxidized by cholesterol oxidase in the sample preparation and 
therefore also react with Girard T reagent. Cholesterol will be visible in the MS 
chromatogram at the chosen conditions. To make sure that cholesterol did not elute at 
the same time as the oxysterols, a mixture of cholesterol and oxysterols were analyzed. 
If cholesterol elute at the same time, ion suppression in ESI can occur. However, as seen 
in Figure 38, cholesterol does not elute from the ACE C18 column before after the 
washing step is applied.  
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Figure 38 EIC (m/z 514.4) of 116 nM 25HC-GT, 20αHC-GT and 22SHC-GT together with EIC (m/z 498.4) of 1212 nM 
Girard T derivatized cholesterol chromatographed on an ACE C18 column, using a mobile phase consisting of 
FA/H2O/ACN (0.1/30/70, v/v/v) at 50 µL/min. After 9 minutes a washing step was applied (FA/H2O/ACN, 
0.1/10/90, v/v/v). Injection volume was 20 µL and sample clean-up was performed as described in Figure 17. Insert 
shows an enlargement of the oxysterols. 
 
Different ratios of cholesterol and oxysterol (Ccholesterol/Coxysterol = 10, 100 and 1000) were 
analysis to examine if cholesterol affected the oxysterols during sample preparation. 
However, even with high cholesterol concentration ratios, the method still produced 
linear curves for the analytes, as shown in Figure 39, where the ball size represent the 
cholesterol/oxysterol ratio. The integrated area is not corrected with the internal 
standard. 
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Figure 39 Linearity curves with different ratio of cholesterol added to the standard solutions. The ball size 
represent cholesterol/oxysterol ratio. Chromatographic conditions as in Figure 17 using a mobile phase consisting 
of FA/H2O/ACN (0.1/30/700, v/v/v). The integrated area is not corrected with internal standard. 
 
R² = 0,9977 
0 
2000000 
4000000 
6000000 
8000000 
10000000 
12000000 
14000000 
-20 0 20 40 60 80 100 120 
Area 
Concentration 25HC (nM) 
25HC 
R² = 0,9863 
0 
2000000 
4000000 
6000000 
8000000 
10000000 
12000000 
-20 0 20 40 60 80 100 120 
Area 
Concentration 24SHC (nM) 
22SHC 
83 
 
6.2 System peak in standards and samples 
When increasing the mobile phase strength to wash out more hydrophobic components 
of the sample, a system peak appears in all samples and standards. This peak appears 
for all analytes and can be caused by poor solubility of analytes in the mobile phase. 
Another explanation for this system peak can be larger retention of the analytes on the 
trap column compared to the analytical column. In addition, secondary interaction can 
occur on both trap and analytical column. Several experiments were conducted to 
address this system peak as described below. 
 
6.2.1 Front flush vs. back flush of load column 
Experiments where the trap column was back flushed was compared with front flushing, 
to examine if the system peak was caused by larger retention on the trap column. If 
some analyte are more retained when the analytical pump front flushes the trap 
column, a split in the peaks may occur. However, no difference in the chromatogram 
was observed when front flushing or back flushing the trap column.  
 
6.2.2 Secondary interaction on the trap column 
To further examine if the system peak was created by the trap or the analytical column, 
experiments where the switching valve was switched back to load position before the 
washing step were carried out. Hence the wash step only elutes compounds from the 
analytical column. If the system peak was due to larger retention on the trap column, it 
should not appear in the chromatogram. However, as shown in Figure 40, the peak still 
84 
 
appears indication that the system peak is due to larger retention on the analytical 
column.  This can be caused by secondary interactions on the analytical column.  
 
 
Figure 40 EIC (m/z 455.4) of a standard solution containing 13 nM 25HC-GT, 20αHC-GT and 22SHC-GT. 
Chromatographic conditions as described in Figure 17. Before the washing step was applied, the valve was 
switched back to load position, so that only the analytical column was washed.  
 
6.2.3 Solubility in the mobile phase 
Experiments using different concentration of ACN in the mobile phase were conducted 
to examine if a higher concentration of ACN gives higher solubility of the analytes and 
removal of the system peak. EIC (m/z 455.4) of the separation with different 
concentration of ACN is shown in Figure 41. When ACN concentration was set to 65 % or 
higher, the system peak disappear, but the resolution was lost, and separation of the 
isomers was not achieved.  
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Figure 41 EIC (m/z 455.4) of a standard solutions containing 13 nM 25HC-GT, 20αHC-GT and 22SHC-
GTchromatographed on a ACE C18 column, using a mobile phase consisting of FA/H2O/ACN (from 0.1/45/55 to 
0.1/20/80, v/v/v) at 75 µL/min. All other conditions as described in Figure 18. 
 
Derivatized oxysterols are more soluble than the oxysterols themselves and MeOH is 
shown to be a better solvent than ACN for lipids, such as cholesterol [40]. However, 
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when ACN was substitute with MeOH in the mobile phase, sufficient resolution was not 
achieved (Figure 42).  Derivatized oxysterols were not eluted until the MeOH 
concentration was over 90 %. With this strong mobile phase, separation of the isomers 
was not achieved. To achieve both sufficient solubility in the mobile phase and 
separation of the isomers, different combinations of solvent containing both MeOH and 
ACN as organic modifier in the mobile phase were studied (se chapter 6.2.4).  
 
 
Figure 42 EIC (m/z 455.4) of a standard solution containing 1.9 nM 25HC-GT, 20αHC-GT and 22SHC-
GTchromatographed on an ACE C18 column, using a mobile phase consisting of FA/H2O/MeOH (0.1/30/70, v/v/v) at 
room temperature.  All other conditions as described in Figure 17.  
 
6.2.4 Addition of MeOH to improve solubility in the mobile phase 
To achieve better solubility in the mobile phase, effects of addition of MeOH to the 
separation mobile phase were studied. A comparison of two different organic solvent 
was performed; FA/ACN (0.1/99.9, v/v) and FA/MeOH/ACN (0.1/30/70, v/v). EIC (m/z 
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455.4) of the latter is shown in Figure 43. As seen from the chromatogram, even with 20 
% MeOH in the mobile phase, the additional peak is still present. In addition, resolution 
is lost due to a needed increase in the percentage of organic solvent (from 55 % to 65 %) 
to be able to elute the analytes from the column. 
 
 
Figure 43 EIC (m/z 455.4) of a standard solution containing 1.9 nM 25HC-GT, 20αHC-GT and 22SHC-
GTchromatographed on an ACE C18 column, using a mobile phase consisting of FA/H2O/MeOH/ACN (0.1/35/20/45, 
v/v/v) with a flow rate of 75 µL/min. After 15 minutes a washing step was applied (FA/H2O/MeOH/ACN 
(0.1/1/29/70 v/v/v/v)).  All other conditions as described in Figure 18.  
 
6.2.5 Solubility in the loading mobile phase 
To examine if the system peak was caused by poor solubility in the loading mobile phase 
(FA/H2O (0.1/99.9, v/v)) experiments with addition of MeOH to the loading mobile 
phase was conducted. Results from using FA/H2O (0.1/99.9, v/v) (n=2), FA/H2O/MeOH 
(0.1/70/30, v/v/v) (n=3) and FA/H2O/MeOH (0.1/40/60, v/v/v) (n=3) as a loading phase 
are shown in Figure 44, Figure 45 and Figure 46, respectively.  
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As seen from the chromatograms, no differences was observed when using FA/H2O 
(0.1/99.9, v/v) or FA/H2O/MeOH (0.1/70/30, v/v/v) in the loading mobile phase. 
However, when increasing the MeOH concentration in the loading mobile phase to 60 % 
breakthrough occur on the load column. The additional peak is present in all 
chromatogram with approximately the same intensity, implying that the additional peak 
is not caused by poor solubility in loading mobile phase.  
 
 
Figure 44 EIC (m/z 455.4) of two injections of a standard solution containing 2.1 nM 25HC-GT, 20αHC-GT and 
22SHC-GT. Chromatographic conditions as described in Figure 18.  
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Figure 45 EIC (m/z 455.4) (n=3) of a standard solution containing 2.1 nM 25HC-GT, 20αHC-GT and 22SHC-GT. 
Loading mobile phase consisted of FA/H2O/MeOH (0.1/70/30, v/v/v). All other conditions as described in Figure 18.  
 
Figure 46 EIC (m/z 455.4) (n=3) of a standard solution containing 2.1 nM 25HC-GT, 20αHC-GT and 22SHC-GT. 
Loading mobile phase consisted of FA/H2O/MeOH (0.1/40/60, v/v/v). All other conditions as described in Figure 18.  
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6.3 13C NMR of 20α hydroxycholesterol 
13C NMR spectra (Figure 47) of the 20α hydroxycholesterol showed splitting of the NMR 
peaks, implying that the 20α hydroxycholesterol is present as mixtures of stereo 
isomers. This can explain the broadness and peak splitting in the LC MS analysis, if the 
stereo isomers have difference in retention factor on the analytical column employed. 
Such (stereo) isomeric mixtures have previously been observed of a related compound 
[36].  An enlargement of two NMR peaks showing peak splitting and an impurity is 
shown in Figure 48 and Figure 49, respectively.  
 
 
Figure 47 
13
C NMR spectra of 20αHC. 
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Figure 48 Enlargement of 
13
C NMR spectra of 20αHC.  
 
Figure 49 Enlargement of 
13
C NMR spectra of 20αHC.  
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6.4 Validation calculations and statistic 
6.4.1 Test for outliers 
Grubbs test was used to examine if any suspected values can be treated as an outlier.  
  
               
                   
 
If number of injection was 3, the G value was compared to the G critical for sample size 
3: 1.155 (p=0.05). If number of injections was 4, the G value was compared to the G 
critical for sample size 4: 1.481 (p=0.05). Standard deviation (STD) was calculated using 
the mean values from each sample without outliers determined from Grubbs test. Some 
replicates at lowest concentration level were rejected. 
 
6.4.2 Between replicates and between day repeatability 
Table 9 and Table 10 shows data used to calculate between replicates (n=6) and 
between days (n=5), respectively.  
Table 9 Between replicate repeatability calculations. 
Replicate Concentration 
(nM) 
A/Ais 25HC A/Ais 24SHC A/Ais 22SHC 
1 0.3 0.0215 0.0238 0.0430 
2 0.3 0.0174 0.0256 0.0457 
3 0.3 0.0125 0.0339 0.0617 
4 0.3 0.0169 0.0304 0.0455 
5 0.3 0.0221 0.0320 0.0534 
6 0.3 0.0188 0.0246 0.0619 
 Average 0.018 0.028 0.052 
 STD 0.003 0.004 0.008 
 RSD (%) 19 15 16 
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Replicate Concentration 
(nM) 
A/Ais 25HC A/Ais 24SHC A/Ais 22SHC 
1 2.1 0.1064 0.1490 0.2320 
2 2.1 0.1041 0.1593 0.2275 
3 2.1 0.1069 0.1577 0.2585 
4 2.1 0.0963 0.1651 0.3178 
5 2.1 0.1009 0.1619 0.2838 
6 2.1 0.1096 0.1395 0.2678 
 Average 0.104 0.1554 0.26 
 STD 0.005 0.009 0.03 
 RSD (%) 5 6 13 
Replicate Concentration 
(nM) 
A/Ais 25HC A/Ais 24SHC A/Ais 22SHC 
1 33 1.7249 2.5207 4.3340 
2 33 1.7504 2.6798 4.4074 
3 33 1.9088 2.9282 4.6159 
4 33 1.7773 2.8765 4.1915 
5 33 1.6866 2.5642 4.0848 
6 33 1.8769 2.6482 4.0883 
 Average 1.8 2.7 4.3 
 STD 0.1 0.2 0.2 
 RSD (%) 5 6 5 
 
Table 10 Between day repeatability calculations. 
Day Concentration 
(nM) 
A/Ais 25HC A/Ais 24SHC A/Ais 22SHC 
1 0.3 0.018 0.028 0.052 
2 0.3 0.0177 0.0189 0.0469 
3 0.3 0.0162 0.0284 0.0477 
4 0.3 0.0179 0.0245 0.0479 
5 0.3 0.0192 0.0285 0.0614 
 Average 0.018 0.026 0.051 
 STD 0.001 0.004 0.006 
 RSD (%) 6 16 12 
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Day Concentration 
(nM) 
A/Ais 25HC A/Ais 24SHC A/Ais 22SHC 
1 2.1 0.104 0.155 0.265 
2 2.1 0.1091 0.1820 0.2761 
3 2.1 0.1255 0.1756 0.2782 
4 2.1 0.1060 0.1881 0.2967 
5 2.1 0.1217 0.1989 0.3535 
 Average 0.11 0.18 0.29 
 STD 0.01 0.02 0.04 
 RSD (%) 9 9 12 
Day Concentration 
(nM) 
A/Ais 25HC A/Ais 24SHC A/Ais 22SHC 
1 33 1.787 2.703 4.287 
2 33 1.9021 2.8073 4.7839 
3 33 1.7103 2.6537 4.1251 
4 33 1.8923 3.3114 4.7016 
5 33 1.9241 2.9963 4.9929 
 Average 1.8 2.9 4.6 
 STD 0.1 0.3 0.4 
 RSD (%) 5 9 8 
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6.5 Automatic filtration and filter flush for robust 
online solid-phase extraction liquid 
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